Abiopharma

🔍 WILSON ALAN D (Director)

Company: Smurfit Westrock plc (SW)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 4,438 shares of Ordinary Shares (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 68,308.23 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,123 shares of Ordinary Shares at $38.39 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 66,185.23 | transaction_form_type: 4 | Footnotes: F3, F2

Footnotes:

• F1: On May 1st, 2026, the Reporting Person was granted 4,438 restricted stock units (RSUs). Each RSU represents a contingent right to receive one ordinary share. The RSUs are scheduled to vest on the earlier of (i) the first anniversary of the date of grant of the RSU or (ii) the date of the next annual meeting of Smurfit Westrock plc's stockholders.
• F2: Includes 57,721.23 fully vested restricted stock units that will be settled in ordinary shares following the Reporting Person's cessation of service as a member of the Issuer's board of directors in accordance with the terms of the WestRock Company 2016 Deferred Compensation Plan for Non-Employee Directors.
• F3: Reflects ordinary shares of Smurfit Westrock plc withheld to satisfy the Reporting Person's tax withholding obligation upon vesting and settlement of RSUs.